$HMMJ.TO

Canopy Growth Q4 Net Loss Narrows, Net Revenue Advances, But Both Miss Forecasts

Canopy Growth (WEED.TO), down 2.1% in U.S. pre-market trading, said on Monday that fourth quarter net loss narrowed as net revenue increased, but both fell short of analyst expectations.Net loss from continuing operations improved to $154.7 million, or $0.40 loss per share, from a net loss of $196 million, or $1.27 loss per share, for the prior year period. The result missed the consensus analyst estimate of a loss of $0.10 per share, according to FactSet.Net revenue advanced from $65 million to $71.2 million, but missed the $74.3 million forecast. Cannabis net revenue jumped 20% to $54.5 million during the quarter. International markets cannabis net revenue of $8.6 million was a 60% increase year over year, due to a smoothing out of supply chain challenges in Europe earlier in the fiscal year.Canopy Growth shares were last seen down US$0.02, to US$0.98, in New York trading.

High Tide to Buy Northern Helm; Secures Credit Approval for C$40 Million of Senior Secured Credit Facilities

High Tide (HITI.V, HITI) agreed to buy 100% of the equity interest of J. Supply Holdings Inc., operating as Northern Helm, resulting in the company's acquisition of four of the six retail cannabis stores currently operated by Northern Helm in Ontario for $7.74 million, it said on Monday.These acquisitions will bring High Tide's total store count to 228 Canna Cabana locations across Canada and 103 in the province of Ontario, it said. The consideration for the 100% of equity interests acquired will be about $3.2 million in assumed debt with a 2% interest rate, with 40% of the remaining amount paid in cash, and the remaining 60% paid in common shares of High Tide on closing on the basis, subject to some terms.In another press release, the company also said it secured credit approval for a loan agreement with Bank of Montreal (BMO.TO, BMO) in respect of new senior secured credit facilities in the principal amount of C$40 million. Closing of the new credit facilities remains subject to some conditions.The new credit facilities will replace its existing senior credit facility, upon closing.U.S.-listed shares of High Tide were last seen up 0.4% at US$2.32 in pre-market trading.

High Tide Moves To Buy Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario

C21 Investments Q4 Loss From Continuing Operations Narrows

C21 Investments (CXXI.CN) overnight Thursday reported a narrowed loss from continuing operations in the fourth quarter even as revenue decreased year-over-year.For the three months ended March 31, 2026, the company reported loss from continuing operations of US$1.4 million or US$0.01 loss per basic and diluted common share, compared with $1.5 million or $0.01 loss per share, a year earlier.Revenue decreased to US$7.5 million compared with $8.1 million, a year-ago, due to seasonality and price compression, it said.Shares of the company closed down 10% to $0.385 on Thursday on the Canadian Securities Exchange.

FLUENT's Interim CEO David E. Vautrin Steps Down; Matt Mundy Appointed as Interim CEO

FLUENT (FNT-U.CN) said Thursday that David E. Vautrin has stepped down as interim chief executive officer, effective June 12, 2026.The company appointed Matt Mundy, its chief legal officer, as interim chief executive officer effective June 12, 2026. Mundy has been "instrumental in advancing the proposed transaction" with Vireo Growth (VREO.CN) and will provide leadership continuity as the company progresses through this next phase, stated the company."On behalf of the Board and the entire FLUENT organization, I would like to thank David for his leadership and commitment during a pivotal period for the Company," said William Smith, Executive Chair of the Board of Directors of the Company. "Over the past year, FLUENT has successfully implemented many critical strategic initiatives, strengthened operational execution and entered into an arrangement agreement to be acquired by Vireo Growth Inc., subject to the terms and conditions contained therein. We are grateful for his service and contributions during this time with the Company."

High Tide to Open Two New Canna Cabana Locations in Welland and Calgary

High Tide (HITI.V) opened a new Canna Cabana branded location in Welland, Ontario, and expects to soon open an additional location in Calgary, Alberta, the company said on Wednesday.These openings bring the company's total store count to 224 Canna Cabana locations across Canada, 99 in the province of Ontario and 92 in the province of Alberta, it said.The company's new Canna Cabana located Welland will begin selling recreational cannabis products and consumption accessories for adult use on June 10.Its new Canna Cabana lin Calgary is expected to begin selling recreational cannabis products and accessories for adult use on June 26, pending regulatory approval."Our growth story continues to be driven by a simple formula: securing strategic real estate in high-potential markets and connecting more consumers to the value offered through our Cabana Club and ELITE programs. The addition of these locations further strengthens our network effect and expands our ability to acquire and retain loyal members across Canada," said chief executive Raj Grover.The company's shares were last seen down $0.02 to $3.25 on the TSX Venture Exchange.Price: $3.24, Change: $-0.03, Percent Change: -0.92%

Herbal Dispatch Completes a 45-Kilorgram Multi-Client Medical Cannabis Export Shipment To Europe

Herbal Dispatch (HERB.CN) on Tuesday said it completed a 452-kilogram international medical-cannabis export shipment to several customers in Germany.The company expects international exports to remain a significant growth driver as it continues expanding its distribution platform and broadening access to regulated medical-cannabis markets worldwide.Herbal Dispatch also said it secured about $200,000 in export financing capacity through its Export Development Canada backed export program and expects financing availability to grow alongside export activity.Shares of the company were last seen up $0.005 to $0.06 on the Canadian Securities Exchange.

Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank

Cresco Labs (CL.CN) announced Monday the closing of a credit agreement with Needham Bank, a Massachusetts-based commercial bank, providing the company with a US$50 million revolving credit facility.The facility bears interest at a fixed annual rate of 7.99% and matures in August 2030, said the company."As a source of non-dilutive capital, the Facility enhances Cresco's ability to pursue strategic opportunities that strengthen the Company's balance sheet and long-term financial profile," stated the company.Borrowings under the facility will be available to fund growth initiatives, acquisitions and general corporate purposes, added the company."This facility reflects both the continued maturation of the industry and Cresco's position within it," said Charlie Bachtell, Chief Executive Officer of Cresco Labs. "Access to conventional bank capital gives us a powerful, non-dilutive tool to accelerate our strategy. As demonstrated by our recent Pennsylvania acquisition, we see significant opportunities to deploy capital into assets that enhance earnings, improve margins and create long-term shareholder value. This added flexibility positions us to drive growth, strengthen our balance sheet and support Cresco as we work toward broader access to U.S. capital markets and a future uplisting to a senior exchange."

Trulieve Cannabis Announces Uplist to NYSE

Trulieve Cannabis' (TRUL.CN) subordinate voting shares have been approved for listing on the New York Stock Exchange (NYSE), the company said on Friday.The subordinate voting shares are expected to begin trading on the NYSE under the symbol "TRLV" at the opening of trading on June 10, 2026.The company anticipates the subordinate voting shares will continue trading on the Canadian Securities Exchange under the symbol "TRUL" and the OTCQX under the symbol "TCNNF" until the close of market on June 9, 2026."Acting Attorney General Todd Blanche reclassified medical marijuana to Schedule III in April 2026, following an Executive Order by President Trump in December 2025," said the company. "The final order issued in April rescheduled state licensed medical marijuana products and created a pathway for Drug Enforcement Administration ("DEA") registration for state licensed medical marijuana businesses under the treaty authority pursuant to the United Nations Single Convention on Narcotic Drugs."Following medical marijuana rescheduling, the company completed a corporate restructuring and investment by a third party resulting in the deconsolidation of operations in markets serving both medical and adult use customers, the company said.The company's remaining consolidated operations consist only of state licensed medical marijuana facilities and include 206 medical marijuana dispensaries supported by 3.5 million square feet of production capacity registered with the DEA, it added."As the first U.S. cannabis company to list on a major U.S. exchange, we are excited for the opportunity to expand our shareholder base, increase liquidity, and raise awareness for the benefits of medical marijuana," said Kim Rivers, Founder and Chief Executive Officer of Trulieve. "Common sense action by President Trump to reclassify medical marijuana to Schedule III paved the way for this historic milestone. Uplisting to the NYSE is a major advancement for Trulieve and the industry."

Emblem Assuming DIP Lending Role From Auxly In Connection with CCAA Proceedings of Ayurcann

Red White & Bloom Brands' Subsidiary, Emblem, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group

Curaleaf Confirms Previously Announced 1-for-3 Reverse Stock Split of Its Subordinate Voting Shares Will Become Effective on June 5, 2026

Cannabix Technologies Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia

Cannabix Technologies (BLO.CN), developer of marijuana and alcohol breath devices, deployed its BreathLogix alcohol screening technology with mining, municipal, and aviation clients in Australia, under terms of an agreement with its exclusive distribution partner in that country, it said on Friday.The BreathLogix device rapidly screens for alcohol using a breath sample while simultaneously capturing a photograph of the user to support identity verification, Friday's statement noted.Shares closed down 7.1% to $0.65 on Thursday on the Canadian Securities Exchange.Price: $0.65, Change: $-0.05, Percent Change: -7.14%

Canopy Growth Relaunches Tweed Brand in Germany With New MTL Cannabis Strain Lineup

Canopy Growth (WEED.TO, CGC) relaunched Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by its unit MTL Cannabis (MTL), it said on Friday.The initial launch includes "Pablo's Revenge, Dante'z Inferno, and Frost'd Flakes" cultivars. Up to five MTL-derived strains are expected to be introduced in June 2026, with further portfolio expansion planned throughout the year, it said.The company also announced that it has been granted a management cease trade order effective as of May 28, by its principal regulator, the Ontario Securities Commission, following its announcement on May 15, regarding certain non-cash technical errors in its accounting. Canopy Growth intends to refile the relevant financial statements in its Annual Report on Form 10-K for the fiscal year ended March 31, 2026, it said.U.S.-listed shares of the company were last seen unchanged at US$1.12 in pre-market trading.

Charlotte's Web Holdings Strengthens Balance Sheet After Closing Transactions with British American Tobacco

Charlotte's Web Holdings (CWEB.TO) has strengthened its balance sheet and enhanced its capital position after closing transactions with British American Tobacco subsidiary BT DE Investments (BAT), Charlotte's Web said overnight Thursday.Charlotte's Web, a provider of hemp extract wellness products, closed the amendment and conversion of BAT's outstanding C$75.3 million principal amount of the convertible debenture into common shares of Charlotte's Web at a conversion price of C$0.94 per share.Charlotte's Web also completed a concurrent additional equity investment by BAT of US$10 million through a private placement priced at C$0.94 per share.The company plans to use the proceeds from the private placements for its participation in the anticipated CMMI Medicare pilot program and other medical channel initiatives.The program creates a pathway for eligible Medicare beneficiaries to access cannabidiol products through consultation with their physician."With increased financial flexibility and a streamlined capital structure, we are better positioned to execute our growth strategy, expand access, and deliver long-term value for our shareholders," Chief Executive Officer Bill Morachnick said.

Jushi Holdings Applies for DEA Registration of State-Licensed Medical Cannabis Operations

Cannabis operator Jushi Holdings (JUSH.CN) has submitted applications to the U.S. Drug Enforcement Administration to register certain state-licensed medical marijuana operations under a federal framework established following the rescheduling of medical marijuana to schedule III, the company said Thursday.The process allows applicants to seek federal registration in connection with the manufacture, distribution, and dispensing of Schedule III medical cannabis products, while relying on existing state medical licenses, Jushi noted.For operators that submit applications within the initial 60-day filing window, registrations may be granted on an expedited basis unless otherwise notified by the DEA, it added.Jushi believes the framework reflects growing federal recognition of state medical cannabis programs and provides a pathway toward greater alignment between state and federal regulation."We are focused on operating at the highest regulatory standards and believe this process represents a meaningful step toward a more integrated and transparent national framework for medical cannabis," Chief Executive Officer Jim Cacioppo said.

Cresco Labs Registers Some Medical Cannabis Facilities With U.S. DEA

Cresco Labs (CL.CN) has registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (DEA) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act, it said on Wednesday.The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in its footprint, it added."For the first time, the work we do is federally recognized-advancing normalization, reducing uncertainty, and reinforcing safe, responsible access to medicine for patients across the country," said Cresco Labs Chief Executive Charlie Bachtell.Shares of the company closed up 4.1% to $1.27 on Tuesday on the Canadian Securities Exchange.

Curaleaf Launches Stock Split Ahead of Planned U.S. Stock Exchange Uplisting

Cannabis company Curaleaf (CURA.TO) has launched a 1-for-3 reverse stock split of its shares ahead of its planned U.S. stock exchange uplisting, the company said Tuesday.The reverse stock split will become effective about June 5 and ensures that the company meets the share price level criteria established by U.S. exchanges.The reverse stock split also allows the company's shares to trade above limits set by certain retail brokerage firms, and to broaden institutional investor participation, Curaleaf said.Following the stock split, Curaleaf's issued and outstanding subordinate voting shares will be reduced to 232,909,336 from 698,728,008 shares."Rescheduling of medical cannabis has created a potential pathway toward uplisting to a major U.S. exchange, and we're now more prepared than ever," CEO Boris Jordan said.

Curaleaf Announcing 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting

Curaleaf (CURA.TO), an international provider of consumer cannabis products, announced Tuesday that a 1-for-3 reverse stock split of its shares will become effective on or about June 5, 2026, as the company prepares for U.S. Stock Exchange uplisting, in response to cannabis rescheduling in that country.Curaleaf's board has approved a proposal to effect a reverse stock split of the company's subordinate voting shares at a ratio of one post-consolidation share for each three pre-consolidation shares, a statement said. This initiative is being done in consultation with major U.S. stock exchanges, and is expected to enable the company to uplist as soon as the opportunity is available, it added.Shares in CURA rose $0.08 or 1.7% at $4.70 in Canada yesterday.

Curaleaf Announcing 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting